Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03299660
Title Avelumab With Chemoradiation in Locally Advanced Rectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia
Indications

rectum adenocarcinoma

Therapies

Avelumab + Capecitabine

Avelumab + Fluorouracil

Age Groups: senior | adult
Covered Countries

Facility Status City State Zip Country Details
Peter MacCallum Cancer Centre Melbourne Victoria 3002 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field